Quick Answer
PTC THERAPEUTICS, INC. reported Long-Term Debt of $285.41 million for fiscal year 2024.
PTC THERAPEUTICS, INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2024 | $285.41M | +0.4% |
| 2023 | $284.21M | -50.3% |
| 2022 | $571.72M | +102.8% |
| 2021 | $281.89M | -8.8% |
| 2020 | $309.14M | +5.2% |
| 2019 | $293.86M | +107.9% |
| 2018 | $141.35M | -2.5% |
| 2017 | $144.97M | +47.6% |
| 2016 | $98.22M | +6.9% |
| 2015 | $91.85M | +20831.2% |
| 2012 | $438.8K | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $286.01M | +0.4% | +0.1% |
| March 31, 2025 | $285.71M | +0.4% | +0.1% |
| December 31, 2024 | $285.41M | +0.4% | +0.1% |
| September 30, 2024 | $285.11M | -50.3% | +0.1% |
| June 30, 2024 | $284.81M | -50.3% | +0.1% |
| March 31, 2024 | $284.51M | -50.3% | +0.1% |
| December 31, 2023 | $284.21M | -50.3% | -50.4% |
| September 30, 2023 | $573.17M | +102.7% | +0.1% |
- PTC THERAPEUTICS, INC. showed an increase of +0.4% in Long-Term Debt compared to the prior fiscal year.
- Over the 2012–2024 period, PTC THERAPEUTICS, INC.’s long-term debt has grown by 64942.3% (from $438.8 thousand to $285.41 million).
- The most recent figure is from PTC THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: